Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jan 16, 16:01
1172.30 -7.95 (-0.67%)
Volume
AVERAGE VOLUME
5-Day
13,390
10-Day
25,681
30-Day
23,411
13,331
  • Prev. Close

    1180.25

  • Open Price

    1171.55

  • Bid Price (Qty.)

    1172.30 (1)

  • Offer Price (Qty.)

    1179.00 (1)

NSE Live

Jan 16, 15:50
1172.70 -7.40 (-0.63%)
Volume
AVERAGE VOLUME
5-Day
813,691
10-Day
1,031,550
30-Day
808,943
909,022
  • Prev. Close

    1180.10

  • Open Price

    1174.20

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1172.70 (585)

Financials

Balance Sheet of Aurobindo Pharma (in Rs. Cr.) Mar 05 Mar 04  
  12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 25.39 25.38  
Total Share Capital 25.39 25.38  
Reserves and Surplus 763.20 730.99  
Total Reserves and Surplus 763.20 730.99  
Total Shareholders Funds 788.59 756.37  
NON-CURRENT LIABILITIES  
Long Term Borrowings 433.78 351.04  
Deferred Tax Liabilities [Net] 76.57 58.30  
Other Long Term Liabilities 0.00 0.00  
Long Term Provisions 0.00 0.00  
Total Non-Current Liabilities 510.35 409.34  
CURRENT LIABILITIES  
Short Term Borrowings 395.34 267.35  
Trade Payables 183.59 129.05  
Other Current Liabilities 11.56 26.04  
Short Term Provisions 10.99 20.25  
Total Current Liabilities 601.48 442.69  
Total Capital And Liabilities 1,935.42 1,643.40  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 578.05 473.00  
Intangible Assets 16.73 0.00  
Capital Work-In-Progress 176.50 111.60  
Other Assets 0.00 0.00  
Fixed Assets 771.28 584.60  
Non-Current Investments 151.27 148.89  
Deferred Tax Assets [Net] 20.59 6.19  
Long Term Loans And Advances 0.00 0.00  
Other Non-Current Assets 0.00 0.00  
Total Non-Current Assets 943.14 739.68  
CURRENT ASSETS  
Current Investments 0.00 0.00  
Inventories 323.58 259.64  
Trade Receivables 441.38 456.85  
Cash And Cash Equivalents 13.80 37.41  
Short Term Loans And Advances 213.50 149.48  
OtherCurrentAssets 0.02 0.34  
Total Current Assets 992.28 903.72  
Total Assets 1,935.42 1,643.40  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 114.91 98.65  
CIF VALUE OF IMPORTS  
Raw Materials 498.21 511.75  
Stores, Spares And Loose Tools 0.00 0.00  
Trade/Other Goods 0.00 0.00  
Capital Goods 32.48 27.84  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 28.69 31.94  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- --  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods 554.62 642.04  
Other Earnings 8.10 2.83  
BONUS DETAILS  
Bonus Equity Share Capital 17.35 17.35  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- --  
Non-Current Investments Unquoted Book Value 151.27 148.89  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- --  
Current Investments Unquoted Book Value -- --  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347